Roger M Perlmutter's Net Worth
$94.7 Million
Who is Roger M Perlmutter?
Roger M Perlmutter has an estimated net worth of $94.7 Million. This is based on reported shares across multiple companies, which include Merck & Co., Inc., NGM BIOPHARMACEUTICALS INC, AMGEN INC, and STEMCELLS INC.
SEC CIK
Roger M Perlmutter's CIK is 0001184228
Past Insider Trading and Trends
2009 was Roger M Perlmutter's most active year for acquiring shares with 6 total transactions. Roger M Perlmutter's most active month to acquire stocks was the month of April. 2005 was Roger M Perlmutter's most active year for disposing of shares, totalling 95 transactions. Roger M Perlmutter's most active month to dispose stocks was the month of October. 2018 saw Roger M Perlmutter paying a total of $12,051,850.46 for 406,757 shares, this is the most they've acquired in one year. In 2018 Roger M Perlmutter cashed out on 450,886 shares for a total of $16,967,967.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Merck & Co., Inc. (MRK) Snapshot price: $117.36
Exe V-P & Pres, MRL
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +19.54% | 35.05K |
$76.56 | $2,683,351.44 | 214.43K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +23.13% | 32.94K |
$80.38 | $2,647,476.06 | 175.34K |
Feb 25
| |||
Form 4
|
—
|
0
|
$60.13 | -$6,827,541.25 | 141.55K |
Nov 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +33.60% | 34.93K |
$54.72 | $1,911,424.32 | 138.91K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +47.40% | 32.67K |
$65.85 | $2,151,319.50 | 101.6K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
| +34.73% | 17.52K |
$54.09 | -$1,457,509.14 | 67.95K |
May 6
| |||
Form 4
| +100.91% | 25.23K |
$50.77 | $1,280,774.79 | 50.23K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NGM BIOPHARMACEUTICALS INC (NGM) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AMGEN INC (AMGN) Snapshot price: $320.56
EVP, Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$64.22 | -$841,575.00 | 186.03K |
Feb 2
| |||
Form 4
| -1.44% | -2.71K |
$56.98 | -$154,643.72 | 186.03K |
Apr 28 - Apr 29
| |||
Form 4
| +8.29% | 14.44K |
$54.69 | -$74,214.33 | 188.75K |
Apr 25 - Apr 26
| |||
Form 4
| -4.48% | -8.18K |
$51.84 | -$423,999.36 | 174.3K |
Mar 11
| |||
Form 4
| +10.62% | 17.52K |
—
|
—
| 182.48K |
Mar 2
| |||
Form 4
| -1.67% | -2.80K |
$58.01 | -$162,544.02 | 164.96K |
Apr 28 - Apr 29
| |||
Form 4
| +7.70% | 12K |
—
|
—
| 167.76K |
Apr 26
| |||
Form 4
| +4.40% | 6.57K |
$57.49 | -$330,739.97 | 155.76K |
Mar 12
| |||
Form 4
|
—
|
0
|
$44.72 | -$1,080,265.00 | 149.19K |
Jun 2
| |||
Form 4
| +7.51% | 10.42K |
$47.63 | -$418,572.44 | 149.19K |
May 7 - May 8
| |||
Form 4
| -0.99% | -1.37K |
$50.44 | -$69,254.12 | 137.4K |
Apr 29
| |||
Form 4
|
∞
| 12K |
—
|
—
| 12K |
Apr 28
| |||
Form 4
| -17.30% | -26.81K |
$41.86 | -$1,122,141.02 | 128.15K |
May 12
| |||
Form 4
| +64.33% | 60.66K |
—
|
—
| 154.95K |
May 7
| |||
Form 4
| +14.58% | 12K |
—
|
—
| 94.3K |
Apr 29
| |||
Form 4
| -25.85% | -28.68K |
$54.25 | -$1,556,107.00 | 82.3K |
May 11
| |||
Form 4
| +129.86% | 62.7K |
—
|
—
| 110.98K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
| -42.03% | -35.00K |
$82.30 | -$2,880,583.70 | 48.28K |
Nov 17
| |||
Form 4
| +72.49% | 35K |
$70.52 | $516,260.40 | 83.28K |
Nov 17
| |||
Form 4
| -13.45% | -7.50K |
$81.20 | -$609,009.75 | 48.28K |
Jul 27 - Aug 27
| |||
Form 4
| +15.53% | 7.5K |
$59.68 | -$1,098,067.75 | 55.78K |
Jul 27
| |||
Form 4
| -18.53% | -10.98K |
$57.35 | -$629,645.65 | 48.28K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| -12.53% | -8.49K |
$58.64 | -$497,853.60 | 59.26K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
$54.58 | -$811,000.00 | 67.75K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
STEMCELLS INC (MBOT) Snapshot price: $0.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +333.33% | 10K |
—
|
—
| 13K |
Dec 14
| |||
Form 4
| +50.00% | 1K |
—
|
—
| 3K |
Dec 14
| |||
Form 4
| +100.00% | 10K |
—
|
—
| 20K |
Dec 14
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |